We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+9.84%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$3.67T
AUM Growth
+$273B
(+8%)
Cap. Flow
+$30.8B
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
4,644
New
41
Increased
3,401
Reduced
945
Closed
112
Avg Time Held
6.4
years
Top 10 Avg Time Held
4.6
years
Top 20 Avg Time Held
4.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$2.67B |
| 2 |
Ferguson
FERG
|
+$2.17B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
Microsoft
MSFT
|
+$2.02B |
| 5 |
Amazon
AMZN
|
+$1.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$3.16B |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$2.44B |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$1.51B |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$1.29B |
| 5 |
Y
Alleghany Corp
Y
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Healthcare | 14.85% |
| 3 | Financials | 14.17% |
| 4 | Industrials | 9.67% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4251
Oxbridge Re Holdings
OXBR
$8.22M
| $261K | ﹤0.01% |
217,164
+61
| +0% | +$111 |
2020 Q4
8 quarters
|
|
4252
i-80 Gold Corp
IAUX
$1.32B
| $259K | ﹤0.01% |
91,845
| – | – |
2022 Q2
2 quarters
|
|
4253
Tao Synergies Inc
TAOX
$27.5M
| $258K | ﹤0.01% |
8,906
+6
| +0.1% | +$837 |
2021 Q4
4 quarters
|
|
4254
Jasper Therapeutics
JSPR
$16.4M
| $256K | ﹤0.01% |
53,044
+32
| +0.1% | +$214 |
2021 Q4
4 quarters
|
|
4255
Xcel Brands
XELB
$2.82M
| $255K | ﹤0.01% |
36,440
+17
| +0% | +$148 |
2017 Q4
20 quarters
|
|
4256
Vivani Medical
VANI
$100M
| $254K | ﹤0.01% |
299,329
+212
| +0.1% | +$345 |
2015 Q2
30 quarters
|
|
4257
Ituran Location and Control
ITRN
$981M
| $254K | ﹤0.01% |
12,029
| – | – |
2017 Q3
21 quarters
|
|
|
TGB
4258
Trekor Metals
TGB
$2.91B
| $254K | ﹤0.01% |
172,780
| – | – |
2022 Q2
2 quarters
|
|
4259
John Wiley & Sons Class B
WLYB
| $253K | ﹤0.01% |
6,415
| – | – |
2020 Q4
8 quarters
|
|
4260
Stran & Co
SWAG
$25.9M
| $253K | ﹤0.01% |
201,085
+151
| +0.1% | +$209 |
2021 Q4
4 quarters
|
|
4261
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $252K | ﹤0.01% |
76,395
| – | – |
2018 Q1
19 quarters
|
|
|
AXLA
4262
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $252K | ﹤0.01% |
30,782
+18
| +0.1% | +$466 |
2019 Q2
14 quarters
|
|
|
EBET
4263
DELISTED
EBET, INC. Common Stock
EBET
| $251K | ﹤0.01% |
13,265
+7
| +0.1% | +$162 |
2021 Q2
6 quarters
|
|
|
ZIVO
4264
DELISTED
Zivo Bioscience, Inc. Common Stock
ZIVO
| $250K | ﹤0.01% |
16,634
+187
| +1% | +$3.26K |
2021 Q4
4 quarters
|
|
4265
DELISTED
T2 Biosystems, Inc
TTOO
| $249K | ﹤0.01% |
1,754
-64
| -4% | -$13.1K |
2014 Q3
33 quarters
|
|
|
RKLY
4266
DELISTED
Rockley Photonics Holdings Limited
RKLY
| $249K | ﹤0.01% |
1,775,302
-32,388
| -2% | -$12.3K |
2021 Q4
4 quarters
|
|
|
DMS
4267
DELISTED
Digital Media Solutions, Inc.
DMS
| $249K | ﹤0.01% |
12,366
+3,080
| +33% | +$77.4K |
2020 Q4
8 quarters
|
|
|
YARW
4268
Yarrow Bioscience
YARW
$158M
| $248K | ﹤0.01% |
1,834
+1
| +0.1% | +$200 |
2018 Q1
19 quarters
|
|
4269
Socket Mobile
SCKT
$3.69M
| $246K | ﹤0.01% |
127,205
+121
| +0.1% | +$244 |
2017 Q4
20 quarters
|
|
4270
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
| $245K | ﹤0.01% |
56,254
+29
| +0.1% | +$138 |
2021 Q4
4 quarters
|
|
4271
Immix Biopharma
IMMX
$677M
| $241K | ﹤0.01% |
105,357
+232
| +0.2% | +$309 |
2022 Q2
2 quarters
|
|
4272
RTB Digital
RTB
$115M
| $241K | ﹤0.01% |
1,502
+68
| +5% | +$19.1K |
2021 Q2
6 quarters
|
|
4273
Edesa Biotech
EDSA
$25.2M
| $240K | ﹤0.01% |
15,840
+24
| +0.2% | +$179 |
2020 Q3
9 quarters
|
|
4274
OLB
OLB
$10.2M
| $239K | ﹤0.01% |
28,491
+21
| +0.1% | +$197 |
2021 Q1
7 quarters
|
|
4275
Theriva Biologics
TOVX
$9.74M
| $239K | ﹤0.01% |
21,015
+12
| +0.1% | +$218 |
2013 Q2
38 quarters
|
|
Similar funds
Vanguard Group's Q4 2022 Portfolio in Review
As of Q4 2022, Vanguard Group held 4,644 positions worth $3.67T, up 8% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 3.3%. Vanguard Group opened 41 new positions and exited 112, leaving the 4,644-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Vanguard Group's largest Q4 2022 buy was U-Haul Holding Co Series N: 8,844,620 shares worth $486M.
- Vanguard Group added most to Prologis in Q4 2022, an estimated $2.67B increase.
- Vanguard Group's biggest Q4 2022 reduction was McKesson, cutting an estimated $868M.
- Vanguard Group fully exited Twitter, Inc. in Q4 2022, selling an estimated $3.16B.
- Vanguard Group's ten largest holdings make up 18% of its $3.67T portfolio in Q4 2022.
- Vanguard Group opened 41 new positions and closed 112 in Q4 2022.
- Vanguard Group's portfolio value rose 8% quarter-over-quarter to $3.67T.
Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.